Tiglutik

U.S. Healthcare

Professionals

TIGLUTIK® (riluzole) is the Only Formulation of Riluzole Indicated for Both Oral and PEG Tube Administration.

CLICK HERE

Ask Your Doctor if
TIGLUTIK® (riluzole)
Is Right for You

CLICK HERE

Ask Your Doctor if
TIGLUTIK® (riluzole)
Is Right for You

CLICK HERE

Why TIGLUTIK?

Developed specifically to meet the
needs of people with ALS

LEARN MORE

TIGLUTIK Support

See how ITF Pharma is committed
to helping the ALS community

LEARN MORE

TIGLUTIK Resources

Review helpful information about
TIGLUTIK and ALS

LEARN MORE

Why start treatment with TIGLUTIK now?

TIGLUTIK is an oral suspension (mildly thick liquid) formulation of riluzole. It was developed specifically to meet the needs of people with ALS. Since TIGLUTIK is approved for use throughout all stages of ALS, patients can start taking it as soon as they are diagnosed with ALS. TIGLUTIK is the only formulation of riluzole approved for both oral and PEG tube administration.

TIGLUTIK

One dose of TIGLUTIK 50 mg (10 mL) is equivalent to one RILUTEK® (riluzole) 50 mg tablet and it is taken twice a day, every 12 hours.

Click here for information to Ask Your Doctor if TIGLUTIK is Right for You.

Expand

Indication

TIGLUTIK (riluzole) is a prescription medicine for the treatment of amyotrophic lateral sclerosis (ALS).

Important Safety Information

You should not take TIGLUTIK if you are allergic to any of its ingredients.
TIGLUTIK can cause liver injury, including death. Your doctor should do blood tests to check your liver function before and during your treatment and may stop treatment with TIGLUTIK if liver function is not normal. Contact your doctor immediately if you have unexplained nausea, vomiting, abdominal pain, fatigue, anorexia, or jaundice and/or dark urine.
Call your doctor immediately if you have a fever, cough, or difficulty in breathing while taking TIGLUTIK.
If you miss or skip a dose of TIGLUTIK, do not take any extra dose to make up for those you missed, but take your prescribed dose at the next regularly scheduled time.
The most common side effects of TIGLUTIK that occurred during medical studies were numbness/tingling around the mouth, weakness, nausea, decreased lung function, high blood pressure, and abdominal pain. If any side effects become troublesome, contact your doctor.
Be sure to tell your doctor and pharmacist about all other health conditions you have and all medicines you are taking, including nonprescription products and vitamins. If you have questions, please talk to your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-332-1088.

Please click here for the Full Prescribing Information.

Intended for U.S. Residents Only

3 Paoli Plaza, Suite C
Paoli, PA 19301 United States
Medical/Product Inquiries: 844-763-1198
EDW Pharma US Headquarters: 610-937-6172
medicalinquiry@edwpharma.com
www.edwpharma.com